Medial Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 28-05-2024
- Paid Up Capital ₹ 1.20 M
as on 28-05-2024
- Company Age 16 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 19.11%
(FY 2022)
- Profit 23.81%
(FY 2022)
- Ebitda 33.48%
(FY 2022)
- Net Worth 9.34%
(FY 2022)
- Total Assets 9.44%
(FY 2022)
About Medial Pharma
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Geeta Goel, Pinki Goel, and Jyoti Goyal serve as directors at the Company.
- CIN/LLPIN
U24232DL2008PLC177932
- Company No.
177932
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
09 May 2008
- Date of AGM
14 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North West Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medial Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geeta Goel  | Director | 06-Jun-2014 | Current |
| Pinki Goel | Director | 06-Jun-2014 | Current |
| Jyoti Goyal | Director | 06-Jun-2014 | Current |
Financial Performance and Corporate Structure Insights of Medial Pharma.
Medial Pharma Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 19.11% increase. The company also saw a substantial improvement in profitability, with a 23.81% increase in profit. The company's net worth moved up by a moderate rise of 9.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medial Pharma?
In 2020, Medial Pharma had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Infar Healthcare Private LimitedActive 16 years 7 monthsGeeta Goel and Pinki Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medial Pharma?
Unlock and access historical data on people associated with Medial Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medial Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medial Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
